CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of C$3.75 and traded as low as C$3.41. CanSino Biologics shares last traded at C$3.41, with a volume of 1,300 shares traded.
CanSino Biologics Stock Performance
The firm’s 50 day simple moving average is C$3.99 and its 200 day simple moving average is C$3.75.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biotechnology company focused on the research, development, manufacturing and commercialization of vaccines. The company develops vaccine technologies intended to address infectious diseases, with activities spanning early-stage research, clinical development, regulatory approval and commercial production.
CanSino’s portfolio includes Convidecia, an adenovirus-based COVID-19 vaccine, and Convidecia Air, an inhaled version designed for respiratory immunization.
Read More
- Five stocks we like better than CanSino Biologics
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
